Women with DCIS at higher risk of death from breast cancer
According to new research, women with ductal carcinoma in situ (DCIS) are more than three times as likely to suffer from breast cancer mortality than women in the general population.
Researchers from the University of Toronto conducted a study, published in JAMA Network Open, that investigated the actual risk of death associated with DCIS in women with a DCIS diagnosis between 1995 and 2014.
“In the population studied, the risk of dying of breast cancer…suggests that our current treatment focus on preventing invasive recurrence is insufficient to eliminate all deaths from breast cancer after DCIS,” said the team led by Vasily Giannakeas, MPH, a doctoral candidate at the University of Toronto and Women’s College Research Institute.
Read more about the findings and their implications on Diagnostic Imaging.
Integrating HCV screening with breast cancer programs enhances care
June 25th 2024A recent study from France demonstrates that incorporating hepatitis C virus screening into breast cancer programs significantly improves patient engagement and access to effective antiviral treatments among older women.
Read More
